The prevalence of nonalcoholic fatty liver disease is increasing.
However, its pathogenesis and clinical significance remain poorly defined, and there is no ideal treatment.
Dr Lian Tock and colleagues assessed the short-term multidisciplinary therapy on visceral adiposity and nonalcoholic fatty liver disease control.
|The intervention reduced visceral adiposity|
|European Journal of Gastroenterology & Hepatology|
The investigative team evaluated and compared the distribution of visceral adiposity and nonalcoholic fatty liver disease.
The team used ultrasonography in 73 post-puberty obese participants.
The participants received multidisciplinary treatment without medications, at the beginning and after 12 weeks of intervention.
The investigators performed descriptive, analysis of variance, and paired t-test.
The team indicated that after intervention the adolescents had a significant reduction in visceral adiposity and nonalcoholic fatty liver disease prevalence.
The investigators emphasized that this was a positive result, because nonalcoholic fatty liver disease can progress to cirrhosis, even in children and adolescents.
Dr Tock's team concludes, “The short-term treatment suggests a profound impact on the control of obesity-related co-morbidities in young people.”